Free Trial

Lipocine (LPCN) SEC Filings & 10K Form

Lipocine logo
$3.44 +0.12 (+3.61%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$3.36 -0.09 (-2.47%)
As of 07/25/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lipocine SEC Filings

DateFilerForm TypeView
07/09/2025
10:01 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025
10:19 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
5:13 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2025
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
4:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
8:30 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
8:30 AM
Lipocine (Filer)
Form DEF 14A
04/10/2025
3:05 PM
Lipocine (Filer)
Form PRE 14A
04/03/2025
3:31 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
8:30 AM
Lipocine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2025
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:00 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:46 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
6:47 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4/A
12/30/2024
7:03 PM
Fogarty Krista (Reporting)
Lipocine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:04 PM
Lipocine (Issuer)
Patel Mahesh V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:06 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
8:45 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:09 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:37 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:05 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:04 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:30 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
8:39 PM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:35 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
10:23 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Critical AI announcement set to ignite AI 2.0 (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
08/08/2024
5:19 AM
Lipocine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
5:20 AM
Lipocine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LPCN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners